# iShares U.S. Pharmaceuticals ETF (IHE)

> Source: Nexqual · https://nexqual.com/IHE · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, iShares U.S. Pharmaceuticals ETF (IHE), nexqual.com/IHE" · informational, not investment advice.

**Price:** USD 102.51 (-2.17% on the day) · last close of Oct 23, 2026; US market after hours, not a live price. Prev close 104.78 · day 102.03–103.87 · 52w 73.76–108.66 · market cap null · PCX

## Key facts
- Total return with dividends: 1Y +38.9% vs S&P 500 +13.4%; 5Y +77.9% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +38.9% | +77.9% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +39.1% | +12.2% |
| Volatility (annualized) | 18.6% | 16.7% |
| Max drawdown | -9.7% (Aug 2026→Oct 2026) | -15.4% (Apr 2022→Oct 2022) |

## Peers
IHF (iShares U.S. Health Care Provid) USD 60.38 -0.85% · XPH (State Street SPDR S&P Pharmaceu) USD 62.7 -2.46% · PJP (Invesco Pharmaceuticals ETF) USD 125.03 -1.79% · IYH (iShares U.S. Healthcare ETF) USD 75.4 -1.08% · IHI (iShares U.S. Medical Devices ET) USD 54.92 +0.09%

## More
Full page: https://nexqual.com/IHE · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt